Insider Buy/Sell Details for the Biotechnology Industry — Last 30 Days
Ratio0.1:1
Daily Buy & Sell Volume
Transactions (889)
Stoke Therapeutics, Inc. (STOK)
Ticho Barry — CHIEF MEDICAL OFFICER
Shares
4,525
Price
$32.01
Total Value
$144.83K
Shares Held After
25,897
% of Holdings
14.9%
Stoke Therapeutics, Inc. (STOK)
Kaye Edward M. MD — Director
Shares
637
Price
$32.47
Total Value
$20.68K
Shares Held After
124,557
% of Holdings
0.5%
Stoke Therapeutics, Inc. (STOK)
Kaye Edward M. MD — Director
Shares
11,930
Price
$32.01
Total Value
$381.85K
Shares Held After
125,194
% of Holdings
8.7%
EyePoint, Inc. (EYPT)
Zaderej Karen L. — Director
Shares
10,600
Price
$4.93
Total Value
$52.26K
Shares Held After
49,100
% of Holdings
21.6%
CYTOKINETICS INC (CYTK)
Malik Fady Ibraham — EVP Research&Development
Shares
3,500
Price
$75.82
Total Value
$265.37K
Shares Held After
153,902
% of Holdings
2.2%
Verrica Pharmaceuticals Inc. (VRCA)
Rosenberg Noah L. — CMO
Shares
2,030
Price
$4.92
Total Value
$9.99K
Shares Held After
8,587
% of Holdings
23.6%
Verrica Pharmaceuticals Inc. (VRCA)
Kirby John J. — Interim CFO
Shares
5,000
Price
$4.93
Total Value
$24.65K
Shares Held After
23,962
% of Holdings
20.9%
NEONC TECHNOLOGIES HOLDINGS, INC. (NTHI)
Heshmatpour Amir F — Director
Shares
9,000
Price
$5.54
Total Value
$49.86K
Shares Held After
3,096,000
% of Holdings
0.3%
AbCellera Biologics Inc. (ABCL)
Montalbano John S. — Director
Shares
10,000
Price
$11.03
Total Value
$110.30K
Shares Held After
251,000
% of Holdings
4.0%
Liquidia Corp (LQDA)
Saggar Rajeev — Chief Medical Officer
Shares
29,534
Price
$76.84
Total Value
$2.27M
Shares Held After
142,265
% of Holdings
17.2%
Adaptive Biotechnologies Corp (ADPT)
ROBINS CHAD M — Director
Shares
2,525
Price
$25.57
Total Value
$64.56K
Shares Held After
2,180,518
% of Holdings
0.1%
Adaptive Biotechnologies Corp (ADPT)
ROBINS CHAD M — Director
Shares
318,799
Price
$25.08
Total Value
$8.00M
Shares Held After
2,183,043
% of Holdings
12.7%
HALOZYME THERAPEUTICS, INC. (HALO)
Torley Helen — Director
Shares
7,500
Price
$103.48
Total Value
$776.12K
Shares Held After
767,780
% of Holdings
1.0%
HALOZYME THERAPEUTICS, INC. (HALO)
Torley Helen — Director
Shares
9,000
Price
$102.55
Total Value
$922.98K
Shares Held After
775,280
% of Holdings
1.1%
HALOZYME THERAPEUTICS, INC. (HALO)
Torley Helen — Director
Shares
2,100
Price
$101.77
Total Value
$213.71K
Shares Held After
784,280
% of Holdings
0.3%
HALOZYME THERAPEUTICS, INC. (HALO)
Torley Helen — Director
Shares
500
Price
$100.46
Total Value
$50.23K
Shares Held After
786,380
% of Holdings
0.1%
HALOZYME THERAPEUTICS, INC. (HALO)
Torley Helen — Director
Shares
900
Price
$98.96
Total Value
$89.06K
Shares Held After
786,880
% of Holdings
0.1%
Adaptive Biotechnologies Corp (ADPT)
NEUPERT PETER M — Director
Shares
69,690
Price
$25.16
Total Value
$1.75M
Shares Held After
130,625
% of Holdings
34.8%
Adaptive Biotechnologies Corp (ADPT)
NEUPERT PETER M — Director
Shares
40,000
Price
$25.10
Total Value
$1.00M
Shares Held After
200,315
% of Holdings
16.6%
Adaptive Biotechnologies Corp (ADPT)
NEUPERT PETER M — Director
Shares
15,000
Price
$25.23
Total Value
$378.45K
Shares Held After
240,315
% of Holdings
5.9%
Neumora Therapeutics, Inc. (NMRA)
Aurora Daljit Singh — Chief Operating and Development Officer
Shares
55,016
Price
$1.50
Total Value
$82.78K
Shares Held After
0
% of Holdings
100.0%
Neumora Therapeutics, Inc. (NMRA)
Aurora Daljit Singh — Chief Operating and Development Officer
Shares
34,020
Price
$1.49
Total Value
$50.53K
Shares Held After
48,750
% of Holdings
41.1%
Neumora Therapeutics, Inc. (NMRA)
Aurora Daljit Singh — Chief Operating and Development Officer
Shares
57,670
Price
$1.51
Total Value
$86.82K
Shares Held After
82,770
% of Holdings
41.1%
Replimune Group, Inc. (REPL)
Hill Emily Luisa — Chief Financial Officer
Shares
9,256
Price
$14.28
Total Value
$132.18K
Shares Held After
215,852
% of Holdings
4.1%
AN2 Therapeutics, Inc. (ANTX)
Readnour Robin Shane — Director
Shares
18,706
Price
$6.01
Total Value
$112.39K
Shares Held After
633,867
% of Holdings
2.9%
AN2 Therapeutics, Inc. (ANTX)
Readnour Robin Shane — Director
Shares
16,696
Price
$6.01
Total Value
$100.31K
Shares Held After
565,592
% of Holdings
2.9%
PTC THERAPEUTICS, INC. (PTCT)
Boulding Mark Elliott — EXEC. VP AND CLO
Shares
969
Price
$72.90
Total Value
$70.64K
Shares Held After
105,272
% of Holdings
0.9%
PTC THERAPEUTICS, INC. (PTCT)
Boulding Mark Elliott — EXEC. VP AND CLO
Shares
1,844
Price
$72.39
Total Value
$133.49K
Shares Held After
106,241
% of Holdings
1.7%
Arcutis Biotherapeutics, Inc. (ARQT)
Welgus Howard G. — Director
Shares
4,730
Price
$26.18
Total Value
$123.83K
Shares Held After
36,475
% of Holdings
11.5%
Enliven Therapeutics, Inc. (ELVN)
Collins Helen Louise — CHIEF MEDICAL OFFICER
Shares
1,100
Price
$59.35
Total Value
$65.28K
Shares Held After
25,000
% of Holdings
4.2%
Enliven Therapeutics, Inc. (ELVN)
Collins Helen Louise — CHIEF MEDICAL OFFICER
Shares
3,900
Price
$58.37
Total Value
$227.65K
Shares Held After
26,100
% of Holdings
13.0%
Avalo Therapeutics, Inc. (AVTX)
Sullivan Christopher Ryan — Chief Financial Officer
Shares
3,749
Price
$19.94
Total Value
$74.76K
Shares Held After
39,900
% of Holdings
8.6%
Avalo Therapeutics, Inc. (AVTX)
Sullivan Christopher Ryan — Chief Financial Officer
Shares
37,945
Price
$19.85
Total Value
$753.33K
Shares Held After
43,649
% of Holdings
46.5%
Keros Therapeutics, Inc. (KROS)
BIENAIME JEAN JACQUES — Director
Shares
1,000
Price
$10.27
Total Value
$10.27K
Shares Held After
19,592
% of Holdings
5.1%
Travere Therapeutics, Inc. (TVTX)
LYONS GARY A — Director
Shares
500
Price
$64.16
Total Value
$32.08K
Shares Held After
61,500
% of Holdings
0.8%
Travere Therapeutics, Inc. (TVTX)
LYONS GARY A — Director
Shares
2,600
Price
$63.50
Total Value
$165.10K
Shares Held After
62,000
% of Holdings
4.0%
Travere Therapeutics, Inc. (TVTX)
LYONS GARY A — Director
Shares
1,900
Price
$62.53
Total Value
$118.80K
Shares Held After
64,600
% of Holdings
2.9%
INSMED Inc (INSM)
SHAROKY MELVIN MD — Director
Shares
5,000
Price
$127.53
Total Value
$637.65K
Shares Held After
0
% of Holdings
100.0%
Candel Therapeutics, Inc. (CADL)
Tyagarajan Seshu — Chief Technology Officer
Shares
7,000
Price
$12.00
Total Value
$84.00K
Shares Held After
76,865
% of Holdings
8.3%
Enliven Therapeutics, Inc. (ELVN)
Hohl Benjamin — CHIEF FINANCIAL OFFICER
Shares
1,388
Price
$59.35
Total Value
$82.38K
Shares Held After
40,036
% of Holdings
3.4%
Enliven Therapeutics, Inc. (ELVN)
Hohl Benjamin — CHIEF FINANCIAL OFFICER
Shares
4,630
Price
$58.35
Total Value
$270.17K
Shares Held After
41,424
% of Holdings
10.1%
Avalo Therapeutics, Inc. (AVTX)
Doyle Mittie — Chief Medical Officer
Shares
1,000
Price
$20.00
Total Value
$20.00K
Shares Held After
51,776
% of Holdings
1.9%
Roivant Sciences Ltd. (ROIV)
Sukhatme Mayukh — Director
Shares
284,707
Price
$36.25
Total Value
$10.32M
Shares Held After
18,630,739
% of Holdings
1.5%
Invivyd, Inc. (IVVD)
Andersen Jill — Chief Legal Officer, Secretary
Shares
37,256
Price
$0.72
Total Value
$26.90K
Shares Held After
314,480
% of Holdings
10.6%
Invivyd, Inc. (IVVD)
Duke William E. — Chief Financial Officer
Shares
22,355
Price
$0.72
Total Value
$16.14K
Shares Held After
187,362
% of Holdings
10.7%
Invivyd, Inc. (IVVD)
Lee Timothy Edward — Chief Commercial Officer
Shares
22,355
Price
$0.72
Total Value
$16.14K
Shares Held After
197,362
% of Holdings
10.2%
Invivyd, Inc. (IVVD)
Allen Robert D. III — Chief Scientific Officer
Shares
20,679
Price
$0.72
Total Value
$14.93K
Shares Held After
195,808
% of Holdings
9.6%
Invivyd, Inc. (IVVD)
Green Julie — Chief Human Resources Officer
Shares
22,355
Price
$0.72
Total Value
$16.14K
Shares Held After
187,362
% of Holdings
10.7%
Disc Medicine, Inc. (IRON)
Quisel John D — Director
Shares
11,888
Price
$79.84
Total Value
$949.16K
Shares Held After
226,064
% of Holdings
5.0%
Disc Medicine, Inc. (IRON)
Quisel John D — Director
Shares
12,712
Price
$79.20
Total Value
$1.01M
Shares Held After
237,952
% of Holdings
5.1%
Showing 51–100 of 889 transactions (page 2 of 18)